Franz H. Messerli

44.4k total citations · 9 hit papers
415 papers, 22.9k citations indexed

About

Franz H. Messerli is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Franz H. Messerli has authored 415 papers receiving a total of 22.9k indexed citations (citations by other indexed papers that have themselves been cited), including 328 papers in Cardiology and Cardiovascular Medicine, 104 papers in Endocrinology, Diabetes and Metabolism and 55 papers in Surgery. Recurrent topics in Franz H. Messerli's work include Blood Pressure and Hypertension Studies (246 papers), Hormonal Regulation and Hypertension (88 papers) and Heart Rate Variability and Autonomic Control (64 papers). Franz H. Messerli is often cited by papers focused on Blood Pressure and Hypertension Studies (246 papers), Hormonal Regulation and Hypertension (88 papers) and Heart Rate Variability and Autonomic Control (64 papers). Franz H. Messerli collaborates with scholars based in United States, Switzerland and Poland. Franz H. Messerli's co-authors include Sripal Bangalore, Ehud Grossman, Edward D. Fröhlich, Roland E. Schmieder, Héctor O. Ventura, Carl J. Pepine, Chirag Bavishi, Sanobar Parkar, Stefano F. Rimoldi and Francis G. Dunn and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Franz H. Messerli

402 papers receiving 21.7k citations

Hit Papers

A Calcium Antagonist vs a... 2003 2026 2010 2018 2003 2007 2006 2004 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
    2003 859 citations Carl J. Pepine, Franz H. Messerli et al. JAMA profile →
  2. Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis
    2007 792 citations Sripal Bangalore, Sanobar Parkar et al. profile →
  3. Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
    2006 619 citations Franz H. Messerli et al. profile →
  4. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension
    2004 536 citations George L. Bakris, Franz H. Messerli et al. JAMA profile →
  5. Essential hypertension
    2007 508 citations Franz H. Messerli et al. profile →
  6. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
    2003 508 citations Franz H. Messerli, Roland E. Schmieder et al. profile →
  7. Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?
    2006 507 citations Franz H. Messerli, Giuseppe Mancia et al. profile →
  8. The Transition From Hypertension to Heart Failure
    2017 351 citations Franz H. Messerli, Stefano F. Rimoldi et al. profile →
  9. Angiotensin-Converting Enzyme Inhibitors in Hypertension
    2018 231 citations Franz H. Messerli, Sripal Bangalore et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz H. Messerli United States 80 16.2k 5.5k 3.2k 2.4k 1.8k 415 22.9k
Michael A. Weber United States 69 16.8k 1.0× 6.5k 1.2× 3.6k 1.1× 3.2k 1.3× 1.4k 0.8× 499 21.9k
Stevo Julius United States 74 22.0k 1.4× 8.3k 1.5× 3.8k 1.2× 2.7k 1.1× 2.3k 1.3× 328 28.2k
Stephen MacMahon Australia 78 16.4k 1.0× 7.0k 1.3× 4.5k 1.4× 2.7k 1.1× 1.8k 1.0× 265 27.6k
Jackson T. Wright United States 56 17.6k 1.1× 5.8k 1.1× 3.4k 1.1× 3.6k 1.5× 2.2k 1.2× 193 27.3k
Joseph L. Izzo United States 43 11.4k 0.7× 4.1k 0.8× 2.2k 0.7× 2.0k 0.8× 1.8k 1.0× 186 18.2k
Daniel W. Jones United States 39 16.0k 1.0× 4.7k 0.9× 5.0k 1.6× 2.5k 1.0× 2.7k 1.5× 115 26.3k
Edward J. Roccella United States 27 15.5k 1.0× 4.5k 0.8× 3.1k 1.0× 3.0k 1.3× 2.3k 1.3× 66 24.3k
Edward D. Fröhlich United States 66 12.0k 0.7× 4.1k 0.8× 2.5k 0.8× 2.4k 1.0× 2.9k 1.6× 497 19.7k
Guıdo Grassı Italy 79 23.8k 1.5× 5.3k 1.0× 4.9k 1.6× 3.0k 1.2× 3.9k 2.2× 703 32.3k
Henry R. Black United States 61 17.7k 1.1× 7.1k 1.3× 3.6k 1.1× 3.2k 1.3× 2.6k 1.5× 260 30.1k

Countries citing papers authored by Franz H. Messerli

Since Specialization
Citations

This map shows the geographic impact of Franz H. Messerli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz H. Messerli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz H. Messerli more than expected).

Fields of papers citing papers by Franz H. Messerli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz H. Messerli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz H. Messerli. The network helps show where Franz H. Messerli may publish in the future.

Co-authorship network of co-authors of Franz H. Messerli

This figure shows the co-authorship network connecting the top 25 collaborators of Franz H. Messerli. A scholar is included among the top collaborators of Franz H. Messerli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz H. Messerli. Franz H. Messerli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parati, Gianfranco, Sripal Bangalore, Grzegorz Bilo, et al.. (2025). Blood pressure variability: a review. Journal of Hypertension. 43(6). 929–938. 7 indexed citations
2.
Boulestreau, Romain, Mateusz Śpiewak, Andrzej Januszewicz, et al.. (2024). Malignant Hypertension:A Systemic Cardiovascular Disease. Journal of the American College of Cardiology. 83(17). 1688–1701. 11 indexed citations
3.
O’Donnell, Martin, Salim Yusuf, Liffert Vogt, Andrew Mente, & Franz H. Messerli. (2023). Potassium intake: the Cinderella electrolyte. European Heart Journal. 44(47). 4925–4934. 8 indexed citations
4.
Januszewicz, Andrzej, Paolo Mulatero, Piotr Dobrowolski, et al.. (2022). Cardiac Phenotypes in Secondary Hypertension. Journal of the American College of Cardiology. 80(15). 1480–1497. 9 indexed citations
5.
Krittanawong, Chayakrit, Hafeez Ul Hassan Virk, Bharat Narasimhan, et al.. (2020). Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis. Progress in Cardiovascular Diseases. 63(4). 527–528. 22 indexed citations
6.
Messerli, Franz H., Sripal Bangalore, Chirag Bavishi, & Stefano F. Rimoldi. (2018). Angiotensin-Converting Enzyme Inhibitors in Hypertension. Journal of the American College of Cardiology. 71(13). 1474–1482. 231 indexed citations breakdown →
7.
Bangalore, Sripal, Robert J. Fakheri, Bora Toklu, et al.. (2016). Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials. Mayo Clinic Proceedings. 91(1). 51–60. 71 indexed citations
8.
Bangalore, Sripal, Sunil Kumar, Alexander Volodarskiy, & Franz H. Messerli. (2012). Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials. Heart. 99(9). 601–613. 40 indexed citations
9.
Frisoli, Tiberio, Roland E. Schmieder, Tomasz Grodzicki, & Franz H. Messerli. (2011). Beyond salt: lifestyle modifications and blood pressure. European Heart Journal. 32(24). 3081–3087. 85 indexed citations
10.
Mancia, Giuseppe, Franz H. Messerli, George L. Bakris, et al.. (2007). Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study. Hypertension. 50(2). 299–305. 134 indexed citations
11.
Bangalore, Sripal, Anupama Shahane, Sanobar Parkar, & Franz H. Messerli. (2007). Compliance and fixed-dose combination therapy. Current Hypertension Reports. 9(3). 184–189. 54 indexed citations
12.
Wang, JG, Jan A. Staessen, Lucas Van Bortel, et al.. (2006). Carotid intima-media thickness and antihypertensive treatment - A meta-analysis of randomized controlled trials. Ghent University Academic Bibliography (Ghent University). 6 indexed citations
13.
Magy, Laurent, F. Vincent, Sébastien Faure, et al.. (2005). The Renin-Angiotensin Systems: Evolving Pharmacological Perspectives for Cerebroprotection. Current Pharmaceutical Design. 11(25). 3275–3291. 16 indexed citations
14.
Lavie, Carl J., et al.. (2004). Left ventricular geometry predicts mortality in elderly with preserved systolic function: an echocardiographic study in 9771 patients over 70 years old. Circulation. 110(17). 516–517. 2 indexed citations
15.
Snider, Stuart R., Franz H. Messerli, Kirn R. Kessler, et al.. (2003). To: The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology. 60(3). 528–528. 1 indexed citations
16.
Messerli, Franz H., et al.. (1998). Panel Discussion: Morbidity and Mortality with Dihydropyridines - the True Benefits Emerge. Blood Pressure. 7(sup1). 33–34.
17.
Messerli, Franz H., William E. Boden, Jørgen Fischer Hansen, & Kenneth B. Schechtman. (1996). Heart rate lowering calcium antagonists (HRL-CA) in hypertensive post MI patients. Journal of the American College of Cardiology. 27(2). 178–178. 7 indexed citations
18.
Zachariah, P K, Franz H. Messerli, & William J. Mroczek. (1993). Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.. PubMed. 15(5). 779–87. 16 indexed citations
19.
Frohlich, E D, et al.. (1991). Hemodynamic effects of celiprolol in essential hypertension. The American Journal of Cardiology. 68(5). 509–514. 6 indexed citations
20.
Messerli, Franz H.. (1984). Hypertension and sudden death : Increased ventricular ectopic activity in left ventricular hypertrophy. JAMA. 77. 18–22. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Weber Breakdown of academic impact, for papers by Stevo Julius Breakdown of academic impact, for papers by Stephen MacMahon Breakdown of academic impact, for papers by Jackson T. Wright Breakdown of academic impact, for papers by Joseph L. Izzo Breakdown of academic impact, for papers by Daniel W. Jones Breakdown of academic impact, for papers by Edward J. Roccella Breakdown of academic impact, for papers by Edward D. Fröhlich Breakdown of academic impact, for papers by Guıdo Grassı Breakdown of academic impact, for papers by Henry R. Black
Rankless by CCL
2026